The Association Between Changes in Alcohol Use and Changes in Antiretroviral Therapy Adherence and Viral Suppression Among Women Living with HIV

Overview

Journal AIDS Behav

Specialty Infectious Diseases

Date 2016 Oct 19

PMID 27752873

Citations 34

Authors

Nikita Barai

Anne Monroe

Catherine Lesko

Bryan Lau

Heidi Hutton

Cui Yang

Anika Alvanzo

Mary Elizabeth McCaul

Geetanjali Chander

Affiliations

Soon will be listed here.

Abstract

Heavy alcohol use has adverse effects in women with HIV. We examined the association between changes in alcohol use (measured with Timeline Followback) and changes in antiretroviral therapy adherence (medication possession ratio) and viral suppression (HIV RNA), measured over 6-month intervals. Among women who were (1) non-adherent or not virologically suppressed and (2) infrequent binge drinkers or non-heavy drinkers at baseline, increasing drinking was significantly associated with lower odds of subsequently improving adherence or viral suppression (OR of becoming adherent of 0.90 in infrequent binge drinkers; OR of becoming suppressed of 0.81 and 0.75 in infrequent binge drinkers and non-heavy drinkers, respectively). Our findings suggest that for these women, increasing drinking may be a barrier to achieving viral suppression. Addressing this barrier by integrating proactive alcohol counseling strategies into routine HIV care may be key to improving viral suppression rates among women retained in HIV care.

Citing Articles

Pain Severity and Experiences with Pain Management Predict Alcohol Use Among Men Who Have Sex with Men Living with HIV.

Ferguson E, Pantalone D, Monti P, Mayer K, Kahler C AIDS Behav. 2025; .

PMID: 39928074 DOI: 10.1007/s10461-025-04652-8.

Associations of stigma, loneliness, and treatment self-regulation with HIV medication adherence among individuals with substance use disorder using a mobile health application.

Tarfa A, Verinumbe T, Yang F, Shiyanbola O, Liebert C, Dietz S Front Public Health. 2024; 12:1440807.

PMID: 39564363 PMC: 11573518. DOI: 10.3389/fpubh.2024.1440807.

Severity and Number of Substances Used are Independently Associated with Antiretroviral Therapy Adherence Over Time among People with HIV in the Current Treatment Era.

Ma J, Delaney J, Ruderman S, Nance R, Hahn A, Drumright L AIDS Behav. 2024; 29(2):468-479.

PMID: 39465466 DOI: 10.1007/s10461-024-04532-7.

Associations of Intimate Partner Violence and Drug Use on Viral Suppression Among Women Living With HIV in South Florida: A Secondary Analysis.

Deaterly C, Richards V, Weaver M, Villalba K, Varma D, Payton I J Assoc Nurses AIDS Care. 2024; 35(3):245-251.

PMID: 38417080 PMC: 11216898. DOI: 10.1097/JNC.0000000000000439.

Alcohol use and the longitudinal HIV care continuum for people with HIV who enrolled in care between 2011 and 2019.

Lesko C, Gnang J, Fojo A, Hutton H, McCaul M, Delaney J Ann Epidemiol. 2023; 85:6-12.

PMID: 37442307 PMC: 10538410. DOI: 10.1016/j.annepidem.2023.07.002.

References

ODonnell A, Anderson P, Newbury-Birch D, Schulte B, Schmidt C, Reimer J . The impact of brief alcohol interventions in primary healthcare: a systematic review of reviews. Alcohol Alcohol. 2013; 49(1):66-78. PMC: 3865817. DOI: 10.1093/alcalc/agt170. View

Hanley J, Negassa A, Edwardes M, Forrester J . Statistical analysis of correlated data using generalized estimating equations: an orientation. Am J Epidemiol. 2003; 157(4):364-75. DOI: 10.1093/aje/kwf215. View

Sohler N, Coleman S, Cabral H, Naar-King S, Tobias C, Cunningham C . Does self-report data on HIV primary care utilization agree with medical record data for socially marginalized populations in the United States?. AIDS Patient Care STDS. 2009; 23(10):837-43. PMC: 2859764. DOI: 10.1089/apc.2009.0056. View

Greenfield S, Pettinati H, OMalley S, Randall P, Randall C . Gender differences in alcohol treatment: an analysis of outcome from the COMBINE study. Alcohol Clin Exp Res. 2010; 34(10):1803-12. PMC: 3048309. DOI: 10.1111/j.1530-0277.2010.01267.x. View

Cook R, Sereika S, Hunt S, Woodward W, Erlen J, Conigliaro J . Problem drinking and medication adherence among persons with HIV infection. J Gen Intern Med. 2001; 16(2):83-8. PMC: 1495171. DOI: 10.1111/j.1525-1497.2001.00122.x. View

Cohen M, Cook J, Grey D, Young M, Hanau L, Tien P . Medically eligible women who do not use HAART: the importance of abuse, drug use, and race. Am J Public Health. 2004; 94(7):1147-51. PMC: 1448413. DOI: 10.2105/ajph.94.7.1147. View

Bajunirwe F, Haberer J, Boum 2nd Y, Hunt P, Mocello R, Martin J . Comparison of self-reported alcohol consumption to phosphatidylethanol measurement among HIV-infected patients initiating antiretroviral treatment in southwestern Uganda. PLoS One. 2014; 9(12):e113152. PMC: 4249861. DOI: 10.1371/journal.pone.0113152. View

Moore R, Bartlett J . Dramatic decline in the HIV-1 RNA level over calendar time in a large urban HIV practice. Clin Infect Dis. 2011; 53(6):600-4. PMC: 3202317. DOI: 10.1093/cid/cir467. View

Steiner J, Koepsell T, Fihn S, Inui T . A general method of compliance assessment using centralized pharmacy records. Description and validation. Med Care. 1988; 26(8):814-23. DOI: 10.1097/00005650-198808000-00007. View

10.

Neblett R, Hutton H, Lau B, McCaul M, Moore R, Chander G . Alcohol consumption among HIV-infected women: impact on time to antiretroviral therapy and survival. J Womens Health (Larchmt). 2011; 20(2):279-86. PMC: 3064875. DOI: 10.1089/jwh.2010.2043. View

11.

Silber Ashley O, Marsden M, Brady T . Effectiveness of substance abuse treatment programming for women: a review. Am J Drug Alcohol Abuse. 2003; 29(1):19-53. DOI: 10.1081/ada-120018838. View

12.

Cook R, Zhu F, Belnap B, Weber K, Cook J, Vlahov D . Longitudinal trends in hazardous alcohol consumption among women with human immunodeficiency virus infection, 1995-2006. Am J Epidemiol. 2009; 169(8):1025-32. PMC: 2727230. DOI: 10.1093/aje/kwp004. View

13.

Lucas G, Gebo K, Chaisson R, Moore R . Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic. AIDS. 2002; 16(5):767-74. DOI: 10.1097/00002030-200203290-00012. View

14.

Hahn J, Dobkin L, Mayanja B, Emenyonu N, Kigozi I, Shiboski S . Phosphatidylethanol (PEth) as a biomarker of alcohol consumption in HIV-positive patients in sub-Saharan Africa. Alcohol Clin Exp Res. 2011; 36(5):854-62. PMC: 3310261. DOI: 10.1111/j.1530-0277.2011.01669.x. View

15.

Zigmond A, SNAITH R . The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983; 67(6):361-70. DOI: 10.1111/j.1600-0447.1983.tb09716.x. View

16.

Berg K, Demas P, Howard A, Schoenbaum E, Gourevitch M, Arnsten J . Gender differences in factors associated with adherence to antiretroviral therapy. J Gen Intern Med. 2004; 19(11):1111-7. PMC: 1196356. DOI: 10.1111/j.1525-1497.2004.30445.x. View

17.

Searles J, Helzer J, Rose G, Badger G . Concurrent and retrospective reports of alcohol consumption across 30, 90 and 366 days: interactive voice response compared with the timeline follow back. J Stud Alcohol. 2002; 63(3):352-62. DOI: 10.15288/jsa.2002.63.352. View

18.

Cook R, Zhu F, Belnap B, Weber K, Cole S, Vlahov D . Alcohol consumption trajectory patterns in adult women with HIV infection. AIDS Behav. 2012; 17(5):1705-12. PMC: 3534826. DOI: 10.1007/s10461-012-0270-6. View

19.

Ammassari A, Trotta M, Murri R, Castelli F, Narciso P, Noto P . Correlates and predictors of adherence to highly active antiretroviral therapy: overview of published literature. J Acquir Immune Defic Syndr. 2003; 31 Suppl 3:S123-7. DOI: 10.1097/00126334-200212153-00007. View

20.

Miguez M, Shor-Posner G, Morales G, Rodriguez A, Burbano X . HIV treatment in drug abusers: impact of alcohol use. Addict Biol. 2003; 8(1):33-7. DOI: 10.1080/1355621031000069855. View